1. Home
  2. LSTA vs CIF Comparison

LSTA vs CIF Comparison

Compare LSTA & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • CIF
  • Stock Information
  • Founded
  • LSTA 1980
  • CIF 1988
  • Country
  • LSTA United States
  • CIF United States
  • Employees
  • LSTA N/A
  • CIF N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • CIF Trusts Except Educational Religious and Charitable
  • Sector
  • LSTA Health Care
  • CIF Finance
  • Exchange
  • LSTA Nasdaq
  • CIF Nasdaq
  • Market Cap
  • LSTA 31.2M
  • CIF 31.5M
  • IPO Year
  • LSTA N/A
  • CIF N/A
  • Fundamental
  • Price
  • LSTA $2.51
  • CIF $1.75
  • Analyst Decision
  • LSTA Strong Buy
  • CIF
  • Analyst Count
  • LSTA 1
  • CIF 0
  • Target Price
  • LSTA $15.00
  • CIF N/A
  • AVG Volume (30 Days)
  • LSTA 58.9K
  • CIF 43.9K
  • Earning Date
  • LSTA 02-27-2025
  • CIF 01-01-0001
  • Dividend Yield
  • LSTA N/A
  • CIF 10.11%
  • EPS Growth
  • LSTA N/A
  • CIF N/A
  • EPS
  • LSTA N/A
  • CIF N/A
  • Revenue
  • LSTA N/A
  • CIF N/A
  • Revenue This Year
  • LSTA N/A
  • CIF N/A
  • Revenue Next Year
  • LSTA N/A
  • CIF N/A
  • P/E Ratio
  • LSTA N/A
  • CIF N/A
  • Revenue Growth
  • LSTA N/A
  • CIF N/A
  • 52 Week Low
  • LSTA $2.19
  • CIF $1.47
  • 52 Week High
  • LSTA $4.20
  • CIF $1.77
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 40.33
  • CIF 53.38
  • Support Level
  • LSTA $2.51
  • CIF $1.73
  • Resistance Level
  • LSTA $2.66
  • CIF $1.76
  • Average True Range (ATR)
  • LSTA 0.19
  • CIF 0.02
  • MACD
  • LSTA -0.01
  • CIF 0.00
  • Stochastic Oscillator
  • LSTA 17.50
  • CIF 75.00

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

Share on Social Networks: